Literature DB >> 12371975

Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria.

Masahiko Tozawa1, Kunitoshi Iseki, Chiho Iseki, Saori Oshiro, Yoshiharu Ikemiya, Shuichi Takishita.   

Abstract

BACKGROUND: Epidemiological data about the relationship between dyslipidemia and proteinuria are sparse. We conducted a retrospective and longitudinal study in a large screened cohort to evaluate whether triglyceride, high-density lipoprotein (HDL) cholesterol, total cholesterol, and low-density lipoprotein (LDL) cholesterol levels increase the risk of development of proteinuria and loss of renal function.
METHODS: Post hoc analysis was performed for 4326 subjects who were free from proteinuria (dipstick 1+ or higher) at baseline (1997) with a follow-up period through 2000. Outcome measures were the development of proteinuria (1+ or higher) and change in glomerular filtration rate (GFR). Multiple logistic analysis and multiple regression analysis were used to analyze baseline characteristics related to the outcome measures.
RESULTS: During the observational period, 505 (11.7%) of subjects had one or more episodes of proteinuria (>/=1+). Adjusted relative risk of triglycerides for one or more incidences of proteinuria was 1.007 (95% CI 1.000 to 1.105, P = 0.04) in men and 1.032 (95% CI 1.004 to 1.061, P = 0.02) in women. Total cholesterol, HDL cholesterol, and LDL cholesterol were not significant predictors of proteinuria. The mean change in GFR between 1997 and 2000 was -6.3 (SD = 9.0) mL/min/1.73 m2 in men, and -7.8 (SD = 10.7) mL/min/1.73 m2 in women. HDL cholesterol (beta = 0.04, t = 3.7, P = 0.0002) in men and triglycerides (per 10 mg/dL, beta = -0.09, t = -2.2, P = 0.02) in women were correlated with the change in GFR.
CONCLUSIONS: High triglyceride levels predicted a risk of developing proteinuria in both men and women, but not total cholesterol nor LDL cholesterol. High triglyceride in women and low HDL cholesterol in men predicted the decline of renal function. It remains to be determined whether prospective treatment of dyslipidemia will protect against renal injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12371975     DOI: 10.1046/j.1523-1755.2002.00626.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  35 in total

Review 1.  Epidemiology of dyslipidemia in chronic kidney disease.

Authors:  Kunitoshi Iseki
Journal:  Clin Exp Nephrol       Date:  2014-01-11       Impact factor: 2.801

2.  Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice.

Authors:  Ping Yang; Yayun Xiao; Xuan Luo; Yunfei Zhao; Lei Zhao; Yan Wang; Tingting Wu; Li Wei; Yaxi Chen
Journal:  J Lipid Res       Date:  2017-05-23       Impact factor: 5.922

Review 3.  Metabolic syndrome and kidney disease: a systematic review and meta-analysis.

Authors:  George Thomas; Ashwini R Sehgal; Sangeeta R Kashyap; Titte R Srinivas; John P Kirwan; Sankar D Navaneethan
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-18       Impact factor: 8.237

4.  Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort.

Authors:  Taku Inoue; Kunitoshi Iseki; Chiho Iseki; Yusuke Ohya; Kozen Kinjo; Shuichi Takishita
Journal:  Clin Exp Nephrol       Date:  2009-05-15       Impact factor: 2.801

5.  Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats.

Authors:  Kasi C McPherson; Lateia Taylor; Ashley C Johnson; Sean P Didion; Aron M Geurts; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-27

6.  Anemia and hypertension are risk factors for both renal prognosis and survival in patients with diabetes mellitus.

Authors:  Yoshie Sasatomi; Hidetoshi Kaneoka; Yasuhiro Abe; Atunori Ishimura; Satoru Ogahara; Toshiaki Murata; Noriko Uesugi; Shigeo Takebayashi; Hiroshi Iwasaki; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2009-05-19       Impact factor: 2.801

Review 7.  An update on the lipid nephrotoxicity hypothesis.

Authors:  Xiong Z Ruan; Zac Varghese; John F Moorhead
Journal:  Nat Rev Nephrol       Date:  2009-10-27       Impact factor: 28.314

8.  Distribution of and factors contributing to chronic kidney disease in a middle-aged working population.

Authors:  Yuka Noborisaka; Masao Ishizaki; Yuichi Yamada; Ryumon Honda; Hitoshi Yokoyama; Masaru Miyao; Masaji Tabata
Journal:  Environ Health Prev Med       Date:  2013-06-02       Impact factor: 3.674

9.  Hypertriglyceridemia accompanied by increased serum complement component 3 and proteinuria in non-nephrotic chronic kidney disease.

Authors:  Kentaro Kohagura; Masako Kochi; Tsuyoshi Miyagi; Takanori Kinjyo; Yuichi Maehara; Kojiro Kinjyo; Kazufumi Nagahama; Atsushi Sakima; Kunitoshi Iseki; Yusuke Ohya
Journal:  Clin Exp Nephrol       Date:  2013-06-12       Impact factor: 2.801

10.  Effects of long-term fenofibrate treatment on markers of renal function in type 2 diabetes: the FIELD Helsinki substudy.

Authors:  Carol Forsblom; Anne Hiukka; Eeva S Leinonen; Jouko Sundvall; Per-Henrik Groop; Marja-Riitta Taskinen
Journal:  Diabetes Care       Date:  2009-10-21       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.